Actineer™ Inc. is a joint venture company between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM) dedicated to advancing Ac-225 technologies, quickly securing supply, and producing industrial-scale quantities of this valuable, rare medical radioisotope for the treatment of cancer. Founded in October 2023, Actineer™ Inc. together with its strong supply chain collaborators will progress Ac-225 development, production and processing technologies to establish short-term production capabilities that will significantly boost international supplies, while working long-term towards the construction of a new Actinium Production Facility (APF) in Canada. The joint venture’s mission is to fulfil the unmet global manufacturing and production needs of this coveted radioisotope with significant potential in the fight against cancer.
| Website | https://www.actineer.com/ |
| Employees | 7 (2 on RocketReach) |
| Founded | 2023 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Radiopharmaceutical Production, Isotope Production, Therapeutic Radiopharmaceuticals, Radioactive Isotopes, Nuclear Medicine, Pharmaceutical Manufacturing, Medical Isotopes, Isotope Separation, Nuclear Medicine Technology, Radiochemistry, Cancer Treatment, Nuclear Technology, Radioactive Materials, Advanced Therapeutics, Drug Development, Oncology, Clinical Trials |
Looking for a particular Actineer, Inc. employee's phone or email?
Actineer, Inc. Questions
Joseph Oliverio is the President and Chief Executive Officer of Actineer, Inc..
2 people are employed at Actineer, Inc..
Top Actineer, Inc. Employees
-
Joseph Oliverio
President and Chief Executive Officer at Actineer, Inc.
Deep River, ON, CA25+ -
Kevin McCaugherty
Vice President Operations and Quality at Actineer, Inc.
Chalk River, ON, CA1
